Published in J Mol Diagn on June 13, 2008
Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA (2006) 7.46
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Detection of Herpes simplex virus DNA by real-time PCR. J Clin Microbiol (2000) 2.29
Detection and subtyping of Herpes simplex virus in clinical samples by LightCycler PCR, enzyme immunoassay and cell culture. BMC Microbiol (2002) 2.17
Laboratory diagnosis of central nervous system infections with herpes simplex virus by PCR performed with cerebrospinal fluid specimens. J Clin Microbiol (1997) 2.08
Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's. Herpes (2004) 1.98
Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions. J Clin Virol (2005) 1.86
Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med (1994) 1.77
Herpes simplex virus type 1 DNA in cerebrospinal fluid of a patient with Mollaret's meningitis. N Engl J Med (1991) 1.69
Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 1.56
Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol (2000) 1.39
Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol (1998) 1.37
Validation of laboratory screening criteria for herpes simplex virus testing of cerebrospinal fluid. J Clin Microbiol (2007) 1.28
Laboratory diagnosis of common herpesvirus infections of the central nervous system by a multiplex PCR assay. J Clin Microbiol (2001) 1.23
Quantitative simultaneous multiplex real-time PCR for the detection of porcine cytokines. J Immunol Methods (2005) 1.17
Routine use of a highly automated and internally controlled real-time PCR assay for the diagnosis of herpes simplex and varicella-zoster virus infections. J Clin Virol (2004) 1.14
Quantitation of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis by the polymerase chain reaction. Clin Diagn Virol (1997) 1.08
Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology (1997) 1.04
Quantitative analysis of herpes simplex virus DNA in cerebrospinal fluid of children with herpes simplex encephalitis. J Med Virol (1993) 1.04
Childhood atopic eczema. BMJ (2002) 0.95
Use of two real-time polymerase chain reactions (PCRs) to detect herpes simplex type 1 and 2-DNA after automated extraction of nucleic acid. J Med Virol (2004) 0.89
Demonstration of herpes simplex type 2 in the cerebrospinal fluid of two patients with recurrent lymphocytic meningitis. N Z Med J (1994) 0.79
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis (2005) 3.52
Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype. Proc Natl Acad Sci U S A (2002) 3.46
Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis (2009) 2.60
Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic Acids Res (2003) 2.37
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology (2009) 1.58
Delayed seroconversion and rapid onset of lymphoproliferative disease after transmission of human T-cell lymphotropic virus type 1 from a multiorgan donor. Clin Infect Dis (2013) 1.48
Technologies for measuring HIV-1 drug resistance. HIV Clin Trials (2002) 1.39
Characterization of virus isolates by particle-associated nucleic acid PCR. J Clin Microbiol (2005) 1.37
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology (2013) 1.30
Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease. J Virol (2007) 1.28
Computational methods for the design of effective therapies against drug resistant HIV strains. Bioinformatics (2005) 1.27
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr (2006) 1.27
Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients. J Clin Virol (2010) 1.23
Tenofovir resistance and resensitization. Antimicrob Agents Chemother (2003) 1.10
First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion (2009) 1.02
Methods for optimizing antiviral combination therapies. Bioinformatics (2003) 1.02
Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology (2013) 1.01
HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge. Intervirology (2012) 0.97
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis (2014) 0.96
Impaired plasmacytoid dendritic cell innate immune responses in patients with herpes virus-associated acute retinal necrosis. J Immunol (2007) 0.91
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology (2012) 0.91
Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy. AIDS Rev (2002) 0.91
Prediction of abacavir resistance from genotypic data: impact of zidovudine and lamivudine resistance in vitro and in vivo. Antimicrob Agents Chemother (2002) 0.90
Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate. J Clin Virol (2009) 0.89
Seroreversion in vertically HIV-1-infected children treated early and efficiently: rule or exception? AIDS (2010) 0.89
Co-ordinated regulation of plasmacytoid dendritic cell surface receptors upon stimulation with herpes simplex virus type 1. Immunology (2009) 0.87
HIV-1 seroreversion following antiretroviral therapy in an HIV-infected child initially presenting with acquired immunodeficiency syndrome. AIDS (2010) 0.87
CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells. Virology (2011) 0.84
Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples. AIDS (2003) 0.83
A reporter system for Epstein-Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate. J Virol Methods (2011) 0.82
Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition. J Acquir Immune Defic Syndr (2011) 0.81
BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition. BMC Nephrol (2013) 0.80
Differential effects of P-class versus other CpG oligodeoxynucleotide classes on the impaired innate immunity of plasmacytoid dendritic cells in HIV type 1 infection. AIDS Res Hum Retroviruses (2010) 0.78
Optimized protocol for detection of HIV-1 drug mutations in patients with low viral load. J Virol Methods (2010) 0.77
[In Process Citation]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2015) 0.77
Safety and efficacy of a NRTI-sparing HAART regimen of efavirenz and lopinavir/ritonavir in HIV-1-infected children. Antivir Ther (2004) 0.77
Hepatitis C and ocular surface disease. Am J Ophthalmol (2007) 0.77
Elevated CD40 ligand silences α interferon production in an HIV-related immune reconstitution inflammatory syndrome. AIDS (2013) 0.75
No evidence for human papillomavirus infection in focal cortical dysplasia IIb. Ann Neurol (2014) 0.75
Images in clinical medicine. Cowpox infection. N Engl J Med (2003) 0.75
Aplastic anemia following hepatitis associated with human herpesvirus 6. J Pediatr Gastroenterol Nutr (2010) 0.75
[In Process Citation]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2015) 0.75
No evidence for persistence of multidrug-resistant viral strains after a 7-month treatment interruption in an HIV-1-infected individual. J Acquir Immune Defic Syndr (2002) 0.75